Mseleni joint disease: A potential model of epigenetic chondrodysplasia

Joint Bone Spine

Volumn 77, Issue 5, 2010, Pages 399-404

  Gibbon, Victoria E ^a,b   Harington, John S ^b   Penny, Clem B ^b   Fredlund, Victor ^c  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Mseleni Hospital   (South Africa)

Author keywords

Chondrodysplasia; Epigenetics; Hip dysplasia; Mseleni; Osteoarthritis; Protrusio acetabuli

Indexed keywords

STABLE ISOTOPE;

ACHONDROPLASIA; ARTHRALGIA; ARTHROPATHY; AUTOIMMUNITY; BONE MINERALIZATION; BRUCELLOSIS; CHONDRODYSPLASIA; DIETARY INTAKE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DWARFISM; ENVIRONMENTAL EXPOSURE; EPIGENETICS; HEREDITY; HIP ARTHROPLASTY; HIP DISEASE; HIP DYSPLASIA; HUMAN; IDIOPATHIC DISEASE; ISOTOPE ANALYSIS; JOINT STIFFNESS; LOCOMOTION; LORDOSIS; MORPHOMETRICS; MORQUIO SYNDROME; MSELENI JOINT DISEASE; OSSIFICATION; OSTEOARTHRITIS; OSTEOCYTE; OSTEOLYSIS; OSTEOPENIA; OSTEOPHYTE; PERTHES DISEASE; SHORT SURVEY; SPONDYLOEPIPHYSEAL DYSPLASIA; WALKING DIFFICULTY;

ADULT; DIET; ENDEMIC DISEASES; EPIGENOMICS; FEMALE; HUMANS; ISOTOPE LABELING; MALE; OSTEOARTHRITIS; OSTEOARTHRITIS, HIP; OSTEOCHONDRODYSPLASIAS; SOUTH AFRICA;

EID: 77957875616     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.01.013     Document Type: Short Survey

References (52)

1. Wittman W., Fellingham S.A. Unusual hip disease in remote part of Zululand. Lancet 1970, 295(7651):842-843.
2. Fellingham S.A., Elphinstone C.D., Wittman W. Mseleni joint disease: background and prevalence. S Afr Med J 1973, 47:2173-2180.
3. Nurse G.T., Jenkins T., Elphinstone C.D. Mseleni joint disease: population genetic studies. S Afr J Sci 1974, 70:360-364.
4. Yach D., Botha J.L. Mseleni joint disease in 1981: decreased prevalence rates, wider geographical location than before, and socioeconomic impact of an endemic osteoarthrosis in an underdeveloped community in South Africa. Int J Epidemiol 1985, 14:276-284.
5. Lubbe A.M., Elphinstone C.D., Fellingham S.A. Mseleni joint disease: food and water supplies. S Afr Med J 1973, 47:2225-2233.
6. Lockitch G., Fellingham S.A., Elphinstone C.D. Mseleni joint disease:a radiological study of two affected families. S Afr Med J 1973, 47:2366-2376.
7. Lockitch G., Fellingham S.A., Wittmann W., et al. Mseleni joint disease: the pilot clinical survey. S Afr Med J 1973, 47:2283-2293.
8. Sokoloff L., Fincham J.E., Du Toit G.T. Pathological features of the femoral head in Mseleni disease. Hum Pathol 1985, 16:117-121.
9. Solomon L., McLaren P., Irwig L., et al. Distinct types of hip disorder in Mseleni joint disease. S Afr Med J 1986, 69:15-17.
10. Fincham J.E., van Rensburg S.J., Marasas W.F.O. Mseleni joint disease - a manganese deficiency?. S Afr Med J 1981, 60:445-447.
11. Schnitzler C.M., Solomon L., Botha J.L., et al. Osteopenia of the pelvis associated with Mseleni joint disease. S Afr Med J 1987, 72:473-475.
12. Schnitzler C.-M., Pieczowski W.M., Fredlund J.M., et al. Histomorphometric analysis of osteopenia associated with endemic osteoarthritis (Mseleni joint disease). Bone 1988, 9:21-27.
13. Marasas W.F.O., van Rensburg S.J. Mycotoxicological investigations on maize and groundnuts from the endemic area of Mseleni joint disease in Kwazulu. S Afr Med J 1986, 69:369-374.
14. Nesterov A.L. The clinical course of Kashin-Beck disease. Arthritis Rheum 1964, 7:29-40.
15. Beighton P. Heritable disorders of the skeleton in Southern Africa: genetic and orthopaedic implications. Trans Coll Med S Afr 1992, 20:75-80.
16. Agarwal S.S., Phadke S.R., Phadke R.V., et al. Handigodu disease: a radiological study. Skeletal Radiol 1994, 23:611-619.
17. Agarwal S.S., Phadke S.R., Fredlund V., et al. Mseleni and Handigodu familial osteoarthropathies: syndromic identity?. Am J Med Genet 1997, 72:435-439.
18. Badadani M., Shetty K.T., Babu S.V.S., et al. Metabolic status of magnesium and ceruloplasmin in Handigodu Joint Disease: A variety of spondylo epi (meta) physeal dysplasia. Clinica Chimica Acta 2008, 395:170-171.
19. Viljoen D., Fredlund V., Ramesar R., et al. Brachydactylous dwarfs of Mseleni. Am J Med Genet 1993, 46:636-640.
20. Peschken C.A., Esdaile J.M. Rheumatic diseases in North America's Indigenous Peoples. Semin Arthritis Rheum 1999, 28:368-391.
21. Waller R.M. Mseleni joint disease: social priorities. Br J Rheumatol 1998, 37:585-586.
22. Bateman C. Mseleni joint disease progress. S Afr J Sci 2000, 38:78.
23. Oliver M.A. Soil and human health: a review. Eur J Soil Sci 1997, 48:573-592.
24. Ceruti P.O., Fey M., Pooley J. Soil nutrient deficiencies in an area of endemic osteoarthritis (Mseleni Joint Disease) and dwarfism in Maputaland, South Africa. Geology and health: closing the gap 2003, 151-154. Oxford University Press, New York. H.C.W. Skinner, A.R. Berger (Eds.).
25. Ceruti PO. Crushed rock and clay amelioration of a nutrient deficient, sandy soil or Maputaland. MSc thesis, Department of Geological Sciences, University of Cape Town June 1999: i-109.
26. Botha G., Porat N. Soil chronosequence development in dunes on the southeast African coastal plain, Maputaland, South Africa. Quat Int 2007, 162-163:111-113.
27. Porat N., Botha G. The luminescence chronology of dune development on the Maputaland coastal plain, southeast Africa. Quat Sci Rev 2008, 27:1024-1046.
28. Mackenzie D.B. Something fishy about Mseleni joint disease. S Afr Med J 1981, 60(24):920.
29. Fincham J.E. Mseleni joint disease. Lancet 1986, 206-207.
30. Fincham J.E., Hough F.S., Taljaard J.J.F., et al. Mseleni joint disease Part I. An animal model?. S Afr Med J 1985, 67:51-57.
31. Fincham J.E., Hough F.S., Taljaard J.J.F., et al. Mseleni joint disease Part II. Low serum calcium and magnesium levels in women. S Afr Med J 1986, 70:740-742.
32. Burger E.J., Elphinstone C.D., Fellingham S.A., et al. Mseleni joint disease: biochemical survey. S Afr Med J 1973, 47:2331-2338.
33. Ballo R., Viljoen D., Machado M., et al. Mseleni joint disease- a molecular genetic approach to defining the aetiology. S Afr Med J 1996, 86:956-958.
34. Martel-Pelletier J., Boileau C., Pelletier J.-P. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008, 22:351-384.
35. Sweet M.B.E., Schnitzler C.M., Hough F.S. Proteoglycans of articular cartilage in Mseleni joint disease. S Afr Med J 1987, 71:317-319.
36. Changelong Y., Fincham J.E., Wright G.C., et al. Mseleni disease serum is not harmful to cultured chondrocytes. Arthritis Rheum 1987, 30:348-352.
37. Nurse G.T. Slow virus in Mseleni joint disease?. Lancet 1985, 2(8458):784.
38. Ford D.K., Stein H.B., Schulzer M., et al. Lymphocytes from the site of disease suggest adenovirus is one cause of persistent or recurrent inflammatory arthritis. J Rheum 1993, 20:75-80.
39. McGlashan N. Mseleni joint disease in Zululand: the borreliosis hypothesis. In: Palagiano C, De Saintis G, Cardillo MC, editors. Atti del Quinto Seminario Internazionale di Geografia medica (Roma, 1-2 dicembre 1994) 1995. p. 462-4.
40. McGlashan N.D., McGlashan H.I., Harington J.S. Mseleni joint disease: an hypothesis and research agendum. S Afr J Sci 1992, 88:552-553.
41. McGlashan N.D., Frean J.A., Harington J.S., et al. Mseleni joint disease: not a borreliosis. Trans R Soc Trop Med Hyg 1997, 91:42-43.
42. Mann D. Aspects of the social effects of Mseleni joint disease: in second Carnegie inquiry into poverty and development in Southern Africa, Cape Town. Conference paper no. 191. 1984:1-13.
43. McLaren P.A., Gear J.S.S., Irwig L.M., et al. Prevalence of motor impairment and disability in a rural community in Kwazulu. Int Rehabil Med 1987, 8:98-104.
44. Editorial Mseleni joint disease. Lancet 1985, 2(8453):483-484.
45. Yamada N., Cheung K.S.C., Tilley S., et al. Does epigenetics play a role in the pathology of osteoarthritis?. J Bone Joint Surg 2006, 88-B:403. [Supplement III].
46. Roach H., Aigner T. DNA methylation in osteoarthritic chondrocytes: a new molecular target. Osteoarthr Cartil 2008, 15:128-137.
47. da Silva M.A., Yamada N., Clarke N.M., et al. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. 1. J Orthop Res 2009, 27:593-601.
48. Iliopoulos D., Malizos K.N., Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007, 66:1616-1621.
49. Cheung K.S., Hashimoto K., Yamada N., et al. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int 2009, 29:525-534.
50. Strietholt S., Maurer B., Peters M.A., et al. Epigenetic modifications in rheumatoid arthritis. Arthritis Res Ther 2008, 10:219.
51. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594.
52. White T.D. Human osteology 2000, Academic Press San Diego, California USA, p. 1-563. Second edition.